XML 48 R41.htm IDEA: XBRL DOCUMENT v3.25.1
Business Combinations - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 3 Months Ended
Mar. 11, 2025
Feb. 03, 2025
Oct. 03, 2023
Mar. 08, 2023
Feb. 29, 2024
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Business Acquisition [Line Items]                
Goodwill           $ 325,774   $ 73,343
Tax benefit from release of a portion of valuation allowance attributable to estimated deferred tax liabilities           46,180 $ (11)  
Net revenue           255,737 145,820  
Net income           (68,037) (64,743)  
Payment to acquire business net of cash acquired           380,762 0  
Maximum [Member]                
Business Acquisition [Line Items]                
Tax benefit from release of a portion of valuation allowance attributable to estimated deferred tax liabilities           46,200    
Genomics Product [Member]                
Business Acquisition [Line Items]                
Net revenue           193,800 $ 102,600  
Ambry [Member]                
Business Acquisition [Line Items]                
Goodwill   $ 231,186            
Business combination aggregate consideration transferred   695,343            
Payments to acquire businesses, gross   397,296            
Base cash consideration   375,000            
Business combination consideration transferred equity interests issued and issuable   298,047            
Amount owed to acquiree under preexisting relationship   3,800            
Transaction costs           5,700    
Acquisition-related costs           3,000    
Goodwill, expected to be deductible for tax purposes   $ 600            
Tax benefit from release of a portion of valuation allowance attributable to estimated deferred tax liabilities           46,200    
Net income           5,500    
Ambry [Member] | Securities Purchase Agreement [Member]                
Business Acquisition [Line Items]                
Business acquisition equity interests issued or issuable number of shares issued   4,843,136            
Ambry [Member] | Common Class A [Member] | Securities Purchase Agreement [Member]                
Business Acquisition [Line Items]                
Class A common stock, closing price   $ 61.54            
Stock issued during period number of shares subject to lock in period   2,152,505            
Ambry [Member] | Genomics Product [Member]                
Business Acquisition [Line Items]                
Net revenue           $ 63,500    
Deep 6 [Member]                
Business Acquisition [Line Items]                
Goodwill $ 21,100              
Business combination aggregate consideration transferred 17,400              
Payments to acquire businesses, gross 4,300              
Business combination consideration in the form of shares held back 800              
Deep 6 [Member] | Other Current Liabilities [Member]                
Business Acquisition [Line Items]                
Business combination consideration in the form of shares held back 800              
Deep 6 [Member] | Common Class A [Member]                
Business Acquisition [Line Items]                
Business combination consideration transferred equity interests issued and issuable $ 13,100              
Sengine [Member]                
Business Acquisition [Line Items]                
Goodwill     $ 9,600          
Business combination aggregate consideration transferred     9,900          
Payments to acquire businesses, gross     2,800          
Business combination consideration in the form of shares held back     1,400          
Sengine [Member] | Maximum [Member]                
Business Acquisition [Line Items]                
Net working capital adjustment     100          
Sengine [Member] | Nonvoting Common Stock [Member]                
Business Acquisition [Line Items]                
Business combination consideration transferred equity interests issued and issuable     $ 6,300          
Business acquisition equity interests issued or issuable number of shares issued     35,000          
Stock issued during the period shares towards working capital adjustment         429      
Mpirik [Member]                
Business Acquisition [Line Items]                
Goodwill       $ 10,600        
Business combination aggregate consideration transferred       9,700        
Business combination consideration transferred equity interests issued and issuable       4,600        
Business combination consideration in the form of shares held back       300        
Business combination aggregate cash consideration payable including the amount witheld       4,700        
Business combination contingent consideration payable in cash at fair value       400        
Business combination cash consideration held back       $ 800        
Mpirik [Member] | Nonvoting Common Stock [Member]                
Business Acquisition [Line Items]                
Stock issued during the period shares in respect of consideration held back       8,724